Dublin, Feb. 26, 2021 (GLOBE NEWSWIRE) -- The "Irritable Bowel Syndrome with Constipation Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, ...
A new irritable bowel syndrome drug is set to hit the US market after regulators gave the green light to Amitiza, developed by Sucampo Pharmaceuticals and co-marketed with Takeda. A new irritable ...
Clinical study results show patients who eliminated foods as determined by the inFoods® IBS test experience significant improvement in IBS Symptoms Including Abdominal Pain Intensity (API) IRVINE, ...
Feb 4 (Reuters) - An experimental drug developed by Furiex Pharmaceuticals Inc met the main goal of a pair of large Phase III clinical trials by significantly alleviating diarrhea and abdominal pain ...
A new value-based approach to the pricing of branded medicines A consultation A new value-based approach to the pricing of branded medicines A consultation The global market for drugs to treat ...
Older treatments for irritable bowel syndrome like peppermint oil safely help ease symptoms and should be used, a review suggests. IBS is characterized by abdominal pain and discomfort accompanied by ...
Spanish pharma company Almirall has moved a step closer to securing EU approval for its irritable bowel syndrome treatment Constella, which remains on track to become the first drug specifically ...
WASHINGTON -- A drug used to treat alcoholics and drug overdoses may also offer relief to people with irritable bowel syndrome. A small trial of 50 patients with the painful disorder found that ...
(Reuters) - Shares of Furiex Pharmaceuticals Inc more than doubled in value after the company said its experimental drug significantly alleviated diarrhea and abdominal pain associated with irritable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback